• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    This Feb. 19, 2013, photo shows OxyContin pills arranged for a photo at a pharmacy, in Montpelier, Vt. The wealthy family who owns the company that makes OxyContin says Massachusetts got the facts wrong in a lawsuit. Legal papers made public Tuesday, April 2, 2019, represent the first time the Sackler family, who owns the Connecticut-based Purdue Pharma, has responded in court to allegations about its role in the opioid crisis.
    Healthcare

    Purdue Pharma and states agree to $4.5 billion OxyContin settlement

    David Hogberg -
    July 8, 2021 4:41 pm
    0
    FILE - A shopper pushes a cart outside Costco Wholesale in Danvers, Mass. in this May 27, 2009 file photo. Costco's fiscal second-quarter net income fell 15 percent, hurt by softer sales of some non-food items, weaker gross margins in its fresh foods business and the impact of weaker foreign currency exchange rates on its international results. Its latest performance missed Wall Street's view. The stock declined in premarket trading on Thursday March 6, 2014. (AP Photo/Elise Amendola, File)
    Healthcare

    Medicare would save billions if it bought generic drugs at Costco prices, study finds

    David Hogberg -
    July 7, 2021 8:33 pm
    0
    Walmart launches house brand of insulin in bid for affordable option
    Healthcare

    Walmart launches house brand of insulin in bid for affordable option

    Cassidy Morrison -
    June 29, 2021 3:22 pm
    0
    Letitia James.
    Healthcare

    Johnson & Johnson reaches $230 million settlement with New York to end opioid business

    Carly Roman -
    June 26, 2021 8:01 pm
    0
    EXCLUSIVE - Bill Maher speaks on stage at the 2014 Television Academy Hall of Fame on Tuesday, March 11, 2014, at the Beverly Wilshire in Beverly Hills, Calif.
    Healthcare

    Bill Maher blasts Big Tech for blocking Wuhan lab leak theory: ‘You were wrong!’

    Lawrence Richard -
    June 26, 2021 6:32 pm
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Healthcare

    Controversial Alzheimer’s drug a godsend for a trial participant, but price tag could put it out of reach

    Cassidy Morrison -
    June 25, 2021 3:00 am
    0
    Liberal watchdog group pushes FDA leadership to resign over controversial Alzheimer’s treatment approval
    Healthcare

    Liberal watchdog group pushes FDA leadership to resign over controversial Alzheimer’s treatment approval

    Cassidy Morrison -
    June 17, 2021 3:36 pm
    0
    Three members of FDA drug review panel resign over approval of $56K Alzheimer’s drug
    Healthcare

    Three members of FDA drug review panel resign over approval of $56K Alzheimer’s drug

    Cassidy Morrison -
    June 11, 2021 2:59 pm
    0
    Moderna requests FDA authorization to give adolescents COVID-19 vaccine
    Healthcare

    Moderna requests FDA authorization to give adolescents COVID-19 vaccine

    Cassidy Morrison -
    June 10, 2021 1:55 pm
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Healthcare

    Medicare Part D benefit design leads to higher costs for specialty drugs

    David Hogberg -
    June 4, 2021 3:00 am
    0
    1...414243...157Page 42 of 157
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.